Cyclooxygenase-2 Expression in Uterine Leiomyosarcomas

REFERENCES

• Silverberg SG. Leiomyosarcoma of the uterus. A clinico-pathologic study. Obstet Gynecol 1971; 38: 613–628.
   Web of Science ®Google Scholar
• Gadducci A, Landoni F, Sartori E, et al. Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996; 62 (1): 25–32.
   PubMed Web of Science ®Google Scholar
• De Paco G, Stefanon B, Raspaglieli F. Neoplasie del corpo dell'utero in Bonadonna G, Robustelli della Cuna G. Medicina oncologica. (6th edition), Masson, Milano-Paris-Barcellona, 1999.
   Google Scholar
• DuBois RN, Giardiello FM, Smalley WE. Non steroidal anti-inflammatory drugs, eicosanoids and colorectal cancer.Gastroenterol Clin North Am 25: 773–791, 1996.
   PubMed Web of Science ®Google Scholar
• Norris AE, Jackson RT, McRae C et al. Non steroidal anti-inflammatory drug and prostate cancer progression. Int J Cancer 1998; 77: 511–515.
   Google Scholar
• Harris RE, Namboodiri KK, Farrar WB et al. Non steroidal anti-inflammatory drugs and breast cancer. Epidemiology 1996; 7: 203–205.
   Google Scholar
• Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001; 1: 11–21.
   PubMed Web of Science ®Google Scholar
• Howe LR, Subbaramaiah K, Patel J et al. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 HER-2)/neu-induced breast cancer. Cancer Res 2002; 62: 5405–5407.
   Google Scholar
• Dannenberg AJ, Altorki NK, Boyle JO et al. Cyclo-oxy-genase 2: a pharmacological target for the prevention of can-cer. Lancet Oncol 2001; 2: 544–551.
   Google Scholar
• Williams CS, Mann M, DuBois RN. The role of cyclooxygenase in inflammation, cancer, and development. Oncogene 1999; 18: 7908–7916.
   PubMed Web of Science ®Google Scholar
• Howe LR, Crawford HC, Subbaramaiah K et al. PEA3 is up-regulated in response to Wntl and activates the expres-sion of cyclooxygenase-2. J Biol Chem 20108-20115, 2001.
   Google Scholar
• Thomas B, Berenbaum F, Humbert L, et al. Critical role of C/EBP delta and C/EBP beta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1 beta in articular chondrocytes. Eur J Biochem 2000; 267: 6798-6809.
   Google Scholar
• Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-3789.
   Google Scholar
• Tomozawa S, Tsuno NH, Sunamio E, et al. Cyclooxygenase-2 overexpression correlates with tumor recur-rence, especially haematogenous metastasis of colorectal can-cer. Br J Cancer 2000; 83: 324–328.
   PubMed Web of Science ®Google Scholar
• Denkert C, Kobel M, Pest S, et al. Expression of cyclooxygenase-2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 2002; 160: 893–903.
   PubMed Web of Science ®Google Scholar
• Ferrandina G, Legge F, Ranelletti FO, et al. Cyclooxygenase-2 expression in endometrial carcinoma: corre-lation with clinicopathologic parameters and clinical outcome. Cancer 2002; 95 (4): 801–807.
   PubMed Web of Science ®Google Scholar
• DiSaia PJ, Sloss JD. Treatment of ovarian cancer: new strategies. Gynecol Oncol 2003; S24–S32.
   Google Scholar
• Tamura M, Sebastian S, Yang S, et al. Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandine E2 and nuclear factor kB. J Biol Chem 2002; 227 (29): 26208-26216.
   Google Scholar
• Kurman RJ. Blaustein's pathology of the female genital tract. 5th ed. 2002, Robert J Kurmann. Spriner-Verlag New York Berlin Heidelberg.
   Google Scholar
• Matsumoto Y, Ishiko O, Sumi T, et al. Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions. Oncol Rep 2001; 8: 1225-1227.
   Google Scholar
• Kaplan EL, Meier P. Nonparametric estimationfrom incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
   Web of Science ®Google Scholar
• TNM Classification of malignant tumours. UICC. Sobin LH and Wittekind Ch Editors. Geneva, Switzerland. Sixth ed. 2002.
   Google Scholar
• Mayerhofer K, Obermairn A, Windbichler G, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74: 196–201.
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Zakim D, Weksler BB et al. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med 1997; 216: 201–210.
   PubMed Web of Science ®Google Scholar
• Huang M, Stolina M, Sharma S et al. Non small cell lung cancer cyclooxygenase-2-dependent regulation of cyto-chine balance in lymphocytes and macrophages: up regulation of interleukin 10 and down-regulation of interleukin 12 pro-duction. Cancer Res 1998; 58: 1208–1216.
   Google Scholar
• Madaan S, Abel PD, Chaudhari KS et al. Cytoplasmatic induction and overexpression of cyclooxyge-nase-2 in human prostate cancer: implication for prevention and treatment: Br J Urol 2000; 86: 736–741.
   Google Scholar
• Tucker ON, Dannemberg AJ, Yang EK et al. Cyclooxygenase-2 expression is upregulated in human pancre-atic cancer. Cancer Res 1999; 59: 987–990.
   PubMed Web of Science ®Google Scholar
• Ohno R, Yoshinaga K, Fujita T et al. Depth of inva-sion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001; 91: 1876–1881.
   Google Scholar
• Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-3340.
   Google Scholar
• Raspollini MR, Amunni G, Villanucci A et al. Expression of inducible nitric oxide synthase and cyclooxyge-nase-2 in ovarian cancer: Correlation with clinical outcome. Gynecol Oncol 2004; 92 (3): 806-812.
   Google Scholar
• Dickens DS, Kozielski R, Leavey PJ, Timmons C, Cripe TP. Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol Oncol 2003; 25 (4): 282–285.
   PubMed Web of Science ®Google Scholar
• Dickens DS, Kozielski R, Khan J, Forus A, Cripe TP. Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 2002; 5 (4): 356–364.
   PubMed Web of Science ®Google Scholar